• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transbound Emerg Dis. Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak

tetano

Editor, Senior Moderator
Transbound Emerg Dis. 2020 Apr 19. doi: 10.1111/tbed.13588. [Epub ahead of print]
Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak.


Bauer DC[SUP]1,[/SUP][SUP]2[/SUP], Tay AP[SUP]1[/SUP], Wilson LOW[SUP]1[/SUP], Reti D[SUP]1[/SUP], Hosking C[SUP]1[/SUP], McAuley AJ[SUP]3[/SUP], Pharo E[SUP]3[/SUP], Todd S[SUP]3[/SUP], Stevens V[SUP]4[/SUP], Neave MJ[SUP]4[/SUP], Tachedjian M[SUP]3[/SUP], Drew TW[SUP]4[/SUP], Vasan SS[SUP]3,[/SUP][SUP]5[/SUP].

Author information




Abstract

Pre-clinical responses to fast moving infectious disease outbreaks heavily depend on choosing the best isolates for animal models that inform diagnostics, vaccines and treatments. Current approaches are driven by practical considerations (e.g. first available virus isolate) rather than a detailed analysis of the characteristics of the virus strain chosen, which can lead to animal models that are not representative of the circulating or emerging clusters. Here, we suggest a combination of epidemiological, experimental and bioinformatics considerations when choosing virus strains for animal model generation. We discuss the currently chosen SARS-CoV-2 strains for international coronavirus disease (COVID-19) models in the context of their phylogeny as well as in a novel alignment-free bioinformatics approach. Unlike phylogenetic trees, which focus on individual shared mutations, this new approach assesses genome-wide co-developing functionalities and hence offers a more fluid view of the "cloud of variances" that RNA viruses are prone to accumulate. This joint approach concludes that while the current animal models cover the existing viral strains adequately, there is substantial evolutionary activity that is likely not considered by the current models. Based on insights from the non-discrete alignment-free approach and experimental observations, we suggest isolates for future animal models.
This article is protected by copyright. All rights reserved.



KEYWORDS:

Alignment-free Phylogeny; Bioinformatics; COVID-19; Genomics; PHEIC; Viral evolution


PMID:32306500DOI:10.1111/tbed.13588
 
Back
Top Bottom